The Role of Natural Extracts in the Management of Infantile Hemangiomas and Vascular Tumors

References

• Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85–94. doi:10.1016/S0140-6736(16)00645-0
   PubMed Web of Science ®Google Scholar
• Tang R, Xian D, Xu J, Peng H, Pan S, Zhong J. Proanthocyanidins as a potential novel way for the treatment of hemangioma. Biomed Res Int. 2021;2021:5695378. doi:10.1155/2021/5695378
   PubMed Web of Science ®Google Scholar
• Ţarcă E, Cojocaru E, Roşu ST, Butnariu LI, Plămădeală P, Moisă ŞM. Differential diagnosis difficulties related to infantile hemangioma - case report and literature review. Rom J Morphol Embryol. 2019;60(4):1375–1379.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ye Z, Tan L, Luo J. Giant hepatic hemangioma regressed significantly without surgical management: a case report and literature review. Front Med Lausanne. 2021;8:712324. doi:10.3389/fmed.2021.712324
   PubMed Web of Science ®Google Scholar
• Darrow DH, Greene AK, Mancini AJ, Nopper AJ; Section on dermatology, section on otolaryngology–head and neck surgery, and section on plastic surgery. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136(4):e1060–e1104. doi:10.1542/peds.2015-2485
   PubMed Web of Science ®Google Scholar
• Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res. 2017;109(11):809–815. doi:10.1002/bdr2.1023
   PubMed Web of Science ®Google Scholar
• Ji Y, Chen S, Li K, Li L, Xu C, Xiang B. Signaling pathways in the development of infantile hemangioma. J Hematol Oncol. 2014;7(1):13. doi:10.1186/1756-8722-7-13
   PubMedGoogle Scholar
• Yang K, Zhang X, Chen L, Chen S, Ji Y. Microarray expression profile of mRNAs and long noncoding RNAs and the potential role of PFK-1 in infantile hemangioma. Cell Div. 2021;16(1):1. doi:10.1186/s13008-020-00069-y
   PubMed Web of Science ®Google Scholar
• Duan P, Huang Y, Chen K, Cheng C, Wu Z, Wu Y. 15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1. Int J Med Sci. 2021;18(14):3214–3223. doi:10.7150/ijms.60774
   PubMed Web of Science ®Google Scholar
• Cai Y, Lv F, Kaldybayeva N, Zhamilya A, Wu Z, Wu Y. 15, 16-dihydrotanshinone I inhibits hemangiomas through inducing pro-apoptotic and anti-angiogenic mechanisms in vitro and in vivo. Front Pharmacol. 2018;9:25. doi:10.3389/fphar.2018.00025
   PubMed Web of Science ®Google Scholar
• Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of tanshen. Med Res Rev. 2007;27(1):133–148. doi:10.1002/med.20077
   PubMed Web of Science ®Google Scholar
• Gordillo GM, Biswas A, Singh K, et al. Mitochondria as target for tumor management of hemangioendothelioma. Antioxid Redox Signal. 2021;34(2):137–153. doi:10.1089/ars.2020.8059
   PubMed Web of Science ®Google Scholar
• Biswas A, Clark EC, Sen CK, Gordillo GM. Phytochemical inhibition of multidrug resistance protein-1 as a therapeutic strategy for hemangioendothelioma. Antioxid Redox Signal. 2017;26(17):1009–1019. doi:10.1089/ars.2016.6881
   PubMed Web of Science ®Google Scholar
• Saqib S, Ullah F, Naeem M, et al. Mentha: nutritional and health attributes to treat various ailments including cardiovascular diseases. Molecules. 2022;27(19):6728. doi:10.3390/molecules27196728
   PubMed Web of Science ®Google Scholar
• Atalay M, Gordillo G, Roy S, et al. Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett. 2003;544(1–3):252–257. doi:10.1016/s0014-5793(03)00509-x
   PubMed Web of Science ®Google Scholar
• Luca AC, Miron IC, Mîndru DE, et al. Optimal nutrition parameters for neonates and infants with congenital heart disease. Nutrients. 2022;14(8):1671. doi:10.3390/nu14081671
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34
   PubMed Web of Science ®Google Scholar
• Lo K, Mihm M, Fay A. Current theories on the pathogenesis of infantile hemangioma. Semin Ophthalmol. 2009;24(3):172–177. doi:10.1080/08820530902805438
   PubMed Web of Science ®Google Scholar
• Li L, Yu J, Cheng S, Peng Z, Luo H. Transcription factor Fli-1 as a new target for antitumor drug development. Int J Biol Macromol. 2022;209(Pt A):1155–1168. doi:10.1016/j.ijbiomac.2022.04.076
   PubMedGoogle Scholar
• Leon–Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg. 2005;58:348–352. doi:10.1016/j.bjps.2004.05.029
   PubMedGoogle Scholar
• de Jong S, Itinteang T, Withers AH, et al. Does hypoxia play a role in infantile hemangioma? Arch Dermatol Res. 2016;308(4):219–227. doi:10.1007/s00403-016-1635-x
   PubMed Web of Science ®Google Scholar
• Chen J, Wu D, Dong Z, Chen A, Liu S. The expression and role of glycolysis-associated molecules in infantile hemangioma. Life Sci. 2020;259:118215. doi:10.1016/j.lfs.2020.118215
   PubMed Web of Science ®Google Scholar
• Yang K, Qiu T, Zhou J, et al. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma. J Transl Med. 2023;21(1):85. doi:10.1186/s12967-023-03932-y
   PubMed Web of Science ®Google Scholar
• Babiak-Choroszczak L, Giżewska-Kacprzak K, Gawrych E, et al. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: are we closer to understand the mechanism of action of propranolol on hemangiomas? Adv Clin Exp Med. 2018;27(5):703–710. doi:10.17219/acem/84800
   PubMed Web of Science ®Google Scholar
• Chen YZ, Bai N, Bi JH, et al. Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms. Braz J Med Biol Res. 2017;50(12): e6138. doi:10.1590/1414-431X20176138
   PubMed Web of Science ®Google Scholar
• Sermeus A, Michiels C. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis. 2011;2(5):e164–e164. doi:10.1038/cddis.2011.48
   PubMedGoogle Scholar
• Song J, Yuan C, Yang J, et al. Novel flavagline-like compounds with potent fli-1 inhibitory activity suppress diverse types of leukemia. FEBS J. 2018;285(24):4631–4645. doi:10.1111/febs.14690
   PubMed Web of Science ®Google Scholar
• Mazzotta C, Marden G, Farina A, Bujor A, Trojanowski MA, Trojanowska M. FLI1 and ERG protein degradation is regulated via cathepsin B lysosomal pathway in human dermal microvascular endothelial cells. Microcirculation. 2021;28(1):e12660. doi:10.1111/micc.12660
   PubMed Web of Science ®Google Scholar
• Luca AC, Miron IC, Trandafir LM, et al. Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics. Rom J Morphol Embryol. 2020;61(3):687–695. doi:10.47162/RJME.61.3.07
   PubMed Web of Science ®Google Scholar
• Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–746. doi:10.1056/NEJMoa1404710
   PubMed Web of Science ®Google Scholar
• Lomenick JP, Reifschneider KL, Lucky AW, et al. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol. 2009;145(3):262–266. doi:10.1001/archdermatol.2008.572
   PubMedGoogle Scholar
• George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004;140(8):963–969. doi:10.1001/archderm.140.8.963
   PubMedGoogle Scholar
• Muñoz-Garza FZ, Ríos M, Roé-Crespo E, et al. Efficacy and safety of topical timolol for the treatment of infantile hemangioma in the early proliferative stage: a randomized clinical trial. JAMA Dermatol. 2021;157(5):583–587. doi:10.1001/jamadermatol.2021.0596
   PubMed Web of Science ®Google Scholar
• Prodromidou A, Machairas N, Garoufalia Z, et al. Liver transplantation for giant hepatic hemangioma: a systematic review. Transplant Proc. 2019;51(2):440–442. doi:10.1016/j.transproceed.2019.01.018
   PubMed Web of Science ®Google Scholar
• Li F, Huang J, Ji D, et al. Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer. Oncol Lett. 2017;14(1):89–96. doi:10.3892/ol.2017.6103
   PubMed Web of Science ®Google Scholar
• Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010;82(4):381–388, 394.
   PubMed Web of Science ®Google Scholar
• Huang S, Yang N, Liu Y, et al. Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling. Nutr Res. 2012;32(7):530–536. doi:10.1016/j.nutres.2012.05.012
   PubMed Web of Science ®Google Scholar
• Yang L, Xian D, Xiong X, Lai R, Song J, Zhong J. Proanthocyanidins against o xidative stress: from molecular mechanisms to clinical applications. Biomed Res. Int. 2018;11. doi:10.1155/2018/8584136.8584136
   Web of Science ®Google Scholar
• Sano A. Safety assessment of 4-week oral intake of proanthocyanidin-rich grape seed extract in healthy subjects. Ood Chem Toxicol. 2017;108(Pt B):519–523. doi:10.1016/j.fct.2016.11.021
   PubMedGoogle Scholar
• Yang L-J, Zhu D-N, Dang Y-L, Zhao X. Treatment of condyloma acuminata in pregnant women with cryotherapy combined with proanthocyanidins: outcome and safety. Exp Ther Med. 2016;11(6):2391–2394. doi:10.3892/etm.2016.3207
   PubMed Web of Science ®Google Scholar
• Afshar K, Stothers L, Scott H, MacNeily AE. Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol. 2012;188(4):1584–1587. doi:10.1016/j.juro.2012.02.031
   PubMed Web of Science ®Google Scholar
• Chen GY, Liu XY, Yan XE, et al. Total flavonoids of rhizoma drynariae treat osteoarthritis by inhibiting arachidonic acid metabolites through AMPK/NFκB pathway. J Inflamm Res. 2023;16:4123–4140. doi:10.2147/JIR.S418345
   PubMed Web of Science ®Google Scholar
• Yang J, Wang Q, Zhao R, et al. Identification of oligomer proanthocyanidins (F2) isolated from grape seeds as a formyl peptide receptor 1 partial agonist. Int Immunopharmacol. 2013;15(4):756–763. doi:10.1016/j.intimp.2013.03.007
   PubMed Web of Science ®Google Scholar
• Mane C, Loonis M, Juhel C, Dufour C, Malien-Aubert C. Food grade lingonberry extract: polyphenolic composition and in vivo protective effect against oxidative stress. J Agric Food Chem. 2011;59(7):3330–3339. doi:10.1021/jf103965b
   PubMed Web of Science ®Google Scholar
• Johnson SA, Arjmandi BH. Evidence for anti-cancer properties of blueberries: a mini-review. Anticancer Agents Med Chem. 2013;13(8):1142–1148. doi:10.2174/18715206113139990137
   PubMed Web of Science ®Google Scholar
• McDougall GJ, Ross HA, Ikeji M, Stewart D. Berry extracts exert different antiproliferative effects against cervical and colon cancer cells grown in vitro. J Agric Food Chem. 2008;56(9):3016–3023. doi:10.1021/jf073469n
   PubMed Web of Science ®Google Scholar
• Olsson ME, Gustavsson KE, Andersson S, Nilsson A, Duan RD. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem. 2004;52(24):7264–7271. doi:10.1021/jf030479p
   PubMed Web of Science ®Google Scholar
• Misikangas M, Pajari A-M, Päivärinta E, et al. Three Nordic berries inhibit intestinal tumorigenesis in multiple intestinal neoplasia/+ mice by modulating β-catenin signaling in the tumor and transcription in the mucosa. J Nutr. 2007;137(10):2285–2290. doi:10.1093/jn/137.10.2285
   PubMed Web of Science ®Google Scholar
• Kelly E, Vyas P, Weber JT. Biochemical properties and neuroprotective effects of compounds in various species of berries. Molecules. 2017;23(1):26. doi:10.3390/molecules23010026
   PubMed Web of Science ®Google Scholar
• Sergazy S, Shulgau Z, Kamyshanskiy Y, et al. Blueberry and cranberry extracts mitigate CCL4-induced liver damage, suppressing liver fibrosis, inflammation and oxidative stress. Heliyon. 2023;9(4):e15370. doi:10.1016/j.heliyon.2023.e15370
   PubMed Web of Science ®Google Scholar
• Bunea A, Rugină D, Sconţa Z, et al. Anthocyanin determination in blueberry extracts from various cultivars and their antiproliferative and apoptotic properties in B16-F10 metastatic murine melanoma cells. Phytochemistry. 2013;95:436–444. doi:10.1016/j.phytochem.2013.06.018
   PubMed Web of Science ®Google Scholar
• Hossain MZ, Shea E, Daneshtalab M, Weber JT. Chemical analysis of extracts from newfoundland berries and potential neuroprotective effects. Antioxidants. 2016;5(4):36. doi:10.3390/antiox5040036
   Web of Science ®Google Scholar
• Trandafir LM, Frăsinariu OE, Țarcă E, et al. Can bioactive food substances contribute to cystic fibrosis-related cardiovascular disease prevention? Nutrients. 2023;15(2):314. doi:10.3390/nu15020314
   PubMed Web of Science ®Google Scholar
• Hoornstra D, Vesterlin J, Pärnänen P, et al. Fermented lingonberry juice inhibits oral tongue squamous cell carcinoma invasion in vitro similarly to curcumin. In Vivo. 2018;32(5):1089–1095. doi:10.21873/invivo.11350
   PubMed Web of Science ®Google Scholar
• Brown EM, Nitecki S, Pereira-Caro G, et al. Comparison of in vivo and in vitro digestion on polyphenol composition in lingonberries: potential impact on colonic health. Bio Fact. 2014;40:611–623. doi:10.1002/biof.1173
   PubMed Web of Science ®Google Scholar
• Koli R, Erlund I, Jula A, Marniemi J, Mattila P, Alfthan G. Bioavailability of various polyphenols from a diet containing moderate amounts of berries. J Agric Food Chem. 2010;58(7):3927–3932. doi:10.1021/jf9024823
   PubMed Web of Science ®Google Scholar
• Zorzi M, Gai F, Medana C, Aigotti R, Peiretti PG. Identification of polyphenolic compounds in edible wild fruits grown in the north-west of Italy by means of HPLC-DAD-ESI HRMS. Plant Foods Hum Nutr. 2020;75(3):420–426. doi:10.1007/s11130-020-00830-2
   PubMed Web of Science ®Google Scholar
• Kowalska K. Lingonberry (Vaccinium vitis-idaea L.) fruit as a source of bioactive compounds with health-promoting Effects-A review. Int J Mol Sci. 2021;22(10):5126. doi:10.3390/ijms22105126
   PubMed Web of Science ®Google Scholar
• Dróżdż P, Šėžienė V, Pyrzynska K. Phytochemical properties and antioxidant activities of extracts from wild blueberries and lingonberries. Plant Foods Hum Nutr. 2017;72(4):360–364. doi:10.1007/s11130-017-0640-3
   PubMed Web of Science ®Google Scholar
• Roy S, Khanna S, Alessio HM, et al. Anti-angiogenic property of edible berries. Free Radic Res. 2002;36(9):1023–1031. doi:10.1080/1071576021000006662
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Li J, Chen X, Fu X, Sun S, Wu Q. Chalcone derivatives: role in anticancer therapy. Biomolecules. 2021;11(6):894. doi:10.3390/biom11060894
   PubMed Web of Science ®Google Scholar
• Gao F, Huang G, Xiao J. Chalcone hybrids as potential anticancer agents: current development, mechanism of action, and structure-activity relationship. Med Res Rev. 2020;40:2049–2084. doi:10.1002/med.21698
   PubMed Web of Science ®Google Scholar
• Lin Y, Zhang M, Lu Q, Xie J, Wu J, Chen C. A novel chalcone derivative exerts anti-inflammatory and anti-oxidant effects after acute lung injury. Aging. 2019;11:7805–7816. doi:10.18632/aging.102288
   PubMedGoogle Scholar
• Mirossay L, Varinska L, Mojzis J. Antiangiogenic effect of flavonoids and chalcones: an update. Int J Mol Sci. 2017;19:27. doi:10.3390/ijms19010027
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Warrier S, Kumar AP, Sethi G, Arfuso F. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol. 2017;15:503–519. doi:10.2174/1570161115666170713094319
   PubMed Web of Science ®Google Scholar
• Iheagwam FN, Ogunlana OO, Ogunlana OE, Isewon I, Oyelade J. Potential anti-cancer flavonoids isolated from Caesalpinia bonduc young twigs and leaves: molecular docking and in silico studies. Bioinform Biol Insights. 2019;13:1177932218821371. doi:10.1177/1177932218821371
   Web of Science ®Google Scholar
• Rozmer Z, Perjési P. Naturally occurring chalcones and their biological activities. Phytochem Rev. 2014;15:87–120. doi:10.1007/s11101-014-9387-8
   Web of Science ®Google Scholar
• Wang C, Chen Y, Wang Y, et al. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1. J Exp Clin Cancer Res CR. 2019;38:371. doi:10.1186/s13046-019-1361-2
   PubMed Web of Science ®Google Scholar
• Lin PH, Chiang YF, Shieh TM, et al. Dietary compound isoliquiritigenin, an antioxidant from licorice, suppresses triple-negative breast tumor growth via apoptotic death program activation in cell and xenograft animal models. Antioxidants (Basel). 2020;9(3):228. doi:10.3390/antiox9030228
   PubMedGoogle Scholar
• Moon D-O, Choi YH, Moon S-K, Kim W-J, Kim G-Y. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells. Toxicol. In Vitro. 2010;24:1927–1934. doi:10.1016/j.tiv.2010.08.002
   Google Scholar
• Lei M, Wang Q, Liu B, Che Y. Two new sesquiterpenes from Sonchus oleraceus and inhibitory mechanism on murine haemangioendothelioma (EOMA) cell lines. Nat Prod Res. 2022;36(11):2814–2820. doi:10.1080/14786419.2021.1931186
   PubMed Web of Science ®Google Scholar
• Khanna S. Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract. Free Radic Biol Med. 2001;31(1):38–42. doi:10.1016/s0891-5849(01)00544-5
   PubMed Web of Science ®Google Scholar
• Roomi MW, Kalinovsky T, Niedzwiecki A, Rath M. Antiangiogenic properties of a nutrient mixture in a model of hemangioma. Exp Oncol. 2009;31(4):214–219.
   PubMedGoogle Scholar
• Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Oncol Rep. 2005;13(3):421–425.
   PubMed Web of Science ®Google Scholar
• Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of ankaferd blood stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010;267:1377–1381. doi:10.1007/s00405-010-1208-0
   PubMed Web of Science ®Google Scholar
• Tasdelen Fisgin N, Tanriverdi Cayci Y, Coban AY, et al. Antimicrobial activity of plant extract ankaferd blood stopper. Fitoterapia. 2009;80:48–50. doi:10.1016/j.fitote.2008.09.006
   PubMed Web of Science ®Google Scholar
• Annagür A, Altunhan H, Konak M, Ors R. Successful use of topical ”ankaferd blood stopper” for repetitive bleedings in an infant with infantile hemangioma. Int J Clin Exp Med. 2012;5(4):342–345.
   PubMed Web of Science ®Google Scholar
• Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract ankaferd blood stopper. J Int Med Res. 2008;36:163–170. doi:10.1177/147323000803600121
   PubMed Web of Science ®Google Scholar
• Shi M, Huang F, Deng C, Wang Y, Kai G. Bioactivities, biosynthesis and biotechnological production of phenolic acids in salvia miltiorrhiza. Crit Rev Food Sci Nutr. 2019;59(6):953–964. doi:10.1080/10408398.2018.1474170
   PubMed Web of Science ®Google Scholar
• Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–422. doi:10.1097/00006534-198203000-00002
   PubMed Web of Science ®Google Scholar
• Xu W, Zhao H. Management of infantile hemangiomas: recent advances. Front Oncol. 2022;12:1064048. doi:10.3389/fonc.2022.1064048
   PubMed Web of Science ®Google Scholar
• Tugcu G, Kirmizibekmez H, Aydin A. The integrated use of in silico methods for the hepatotoxicity potential of piper methysticum. Food Chem Toxicol. 2020;145:111663. doi:10.1016/j.fct.2020.111663
   PubMed Web of Science ®Google Scholar
• Țarcă V, Țarcă E, Luca FA. The impact of the main negative socio-economic factors on female fertility. Healthcare. 2022;10(4):734. doi:10.3390/healthcare10040734
   Web of Science ®Google Scholar
• Malkan UY, Haznedaroglu IC. Antineoplastic effects of ankaferd hemostat. Biomed Res Int. 2022;2022:2665903. doi:10.1155/2022/2665903
   PubMed Web of Science ®Google Scholar